Mayne Pharma Group Balance Sheet Health
Financial Health criteria checks 6/6
Mayne Pharma Group has a total shareholder equity of A$547.8M and total debt of A$30.0M, which brings its debt-to-equity ratio to 5.5%. Its total assets and total liabilities are A$1.2B and A$604.9M respectively.
Key information
5.5%
Debt to equity ratio
AU$30.02m
Debt
Interest coverage ratio | n/a |
Cash | AU$154.81m |
Equity | AU$547.77m |
Total liabilities | AU$604.88m |
Total assets | AU$1.15b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: MAYN.F's short term assets (A$475.3M) exceed its short term liabilities (A$295.7M).
Long Term Liabilities: MAYN.F's short term assets (A$475.3M) exceed its long term liabilities (A$309.2M).
Debt to Equity History and Analysis
Debt Level: MAYN.F has more cash than its total debt.
Reducing Debt: MAYN.F's debt to equity ratio has reduced from 30.4% to 5.5% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: MAYN.F has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: MAYN.F has sufficient cash runway for 1.1 years if free cash flow continues to reduce at historical rates of 48.2% each year.